Composite Indices Using 3 or 4 Components of the Core Data Set Have Similar Predictive Ability to Measure Disease Activity in RA: Evidence from the DANCER and REFLEX Studies

por Bergman, Martin J., Reiss, William, Chung, Carol, Wong, Pamela, Turpcu, Adam
Publicado 2013

Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis

por Reiss, William G., Devenport, Jenny N., Low, Jason M., Wu, George, Sasso, Eric H.
Publicado 2015

Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry

por Pappas, Dimitrios A., Blachley, Taylor, Best, Jennie H., Zlotnick, Steve, Reiss, William G., Emeanuru, Kelechi, Kremer, Joel M.
Publicado 2021

Comparative Efficacy (DAS28 Remission) of Targeted Immune Modulators for Rheumatoid Arthritis: A Network Meta-Analysis

por Best, Jennie H., Kuang, Yuting, Jiang, Yilin, Singh, Rajpal, Karabis, Andreas, Uyei, Jennifer, Dang, Joseph, Reiss, William G.
Publicado 2021

Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study

por Pritchard, Charles H, Greenwald, Maria W, Kremer, Joel M, Gaylis, Norman B, Rigby, William, Zlotnick, Steve, Chung, Carol, Jaber, Birgit, Reiss, William
Publicado 2014

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

por Salama, Carlos, Han, Jian, Yau, Linda, Reiss, William G., Kramer, Benjamin, Neidhart, Jeffrey D., Criner, Gerard J., Kaplan-Lewis, Emma, Baden, Rachel, Pandit, Lavannya, Cameron, Miriam L., Garcia-Diaz, Julia, Chávez, Victoria, Mekebeb-Reuter, Martha, Lima de Menezes, Ferdinando, Shah, Reena, González-Lara, Maria F., Assman, Beverly, Freedman, Jamie, Mohan, Shalini V.
Publicado 2020